Under the agreement, the University will provide OpenBench with promising drug candidates and OpenBench will conduct a virtual screening. The company will be paid upon delivering the leads to the University, according to a Nov. 9 OpenBench news release.
“As Carolina researchers develop critical therapeutics for cancer and other diseases, we look for new and innovative ways to move potential treatments to market faster, so that patients can benefit sooner,” UNC Chief Innovation Officer Michelle Bolas said. “We are delighted to team with OpenBench to unlock the commercial and therapeutic potential of emerging scientific discoveries.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
